Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: Beneficial effect of bexarotene [7]

British Journal of Dermatology

Volumn 156, Issue 3, 2007, Pages 584-586

  Mitteldorf, C ^a   Stadler, R ^b   Bertsch, H P ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KLINIKUM MINDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; ISOTRETINOIN;

ADULT; ANAMNESIS; CASE REPORT; CELL TRANSFORMATION; COMEDO; DRUG EFFECT; FEMALE; HEALING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LETTER; LOW DRUG DOSE; MYCOSIS FUNGOIDES; PHOTOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SKIN CYST; SYSTEMIC THERAPY; T LYMPHOCYTE; TREATMENT DURATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; MYCOSIS FUNGOIDES; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES;

EID: 33846980418     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07672.x     Document Type: Letter

References (10)

1. Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol 2004; 18:397-415.
2. Flaig MJ, Cerroni L, Schuhmann K et al. Follicular mycosis fungoides. A histopathologic analysis of nine cases. J Cutan Pathol 2001; 28:525-30.
3. Leverkus M, Rose C, Bröcker E-B, Goebeler M. Follicular cutaneous T-cell lymphoma: beneficial effect of isotretinoin for persisting cysts and comedones. Br J Dermatol 2005; 152:176-98.
4. Lacour JP, Castanet J, Perrin C, Ortonne JP. Follicular mycosis fungoides. J Am Acad Dermatol 1993; 29:330-4.
5. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85.
6. Apisarnthanarax N, Ha CS, Duvic M. Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation: successful treatment using radiation therapy plus oral bexarotene combination therapy. Am J Clin Dermatol 2003; 4:429-33.
7. Shistik G, Scalf LA, Fenske N, Glass LF. Follicular mucosis fungoides: successful treatment with oral bexarotene. J Drugs Dermatol 2004; 3:301-4.
8. Duvic M, Martin AG, Kim Y et al. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 2001; 137:581-93.
9. Kreuter A, Altmeyer P. Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome. J Am Acad Dermatol 2005; 53:1093-5.
10. Bouwhuis SA, Davis MDP, el-Azhary RA et al. Bexarotene treatment of late-stage mycosis fungoides and Se'zary-syndrome: development of extracutaneous lymphoma in 6 patients. J Am Acad Dermatol 2005; 52:991-6.